Actuate Therapeutics, Inc. Common stock Share Price
NASDAQ: ACTU | Micro CapActuate Therapeutics, Inc. Common stock Stock Performance
Open $1.23 | Prev. Close $1.22 | Circuit Range N/A |
Day Range $1.19 - $1.23 | Year Range $1.03 - $9.10 | Volume 1,403 |
Average Traded $1.19 |
Actuate Therapeutics, Inc. Common stock Share Price Today
As of 10 August 2026, Actuate Therapeutics, Inc. Common stock's share price is $1.10. The stock opened at $1.23, compared to its previous close of $1.22. During today's trading session, Actuate Therapeutics, Inc. Common stock's share price traded between $1.19 and $1.23, with an average price of $1.21. Over the past 52 weeks, the stock has recorded a high of $9.10 and a low of $1.03. In terms of performance, Actuate Therapeutics, Inc. Common stock's share price has declined by 70.92% over the last six months and is down 86.87% on a year-on-year basis.
Actuate Therapeutics, Inc. Common stock Share Price Chart
Actuate Therapeutics, Inc. Common stock Stock Fundamentals & Key Indicators
Market Cap $23.23M | PE Ratio (TTM) -1.04 | Dividend Yield N/A |
EPS (TTM) $-1.06 | Revenue (TTM) N/A | Return On Equity (TTM) -280.51% |
Profit Margin N/A | Debt to Equity 0.72 | Quarterly Earnings Growth YoY 9.44% |
Actuate Therapeutics, Inc. Common stock Quarterly Profit & Loss
All figures in USD
Actuate Therapeutics, Inc. Common stock Annual Profit & Loss
All figures in USD
About Actuate Therapeutics, Inc. Common stock
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as metastatic melanoma and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.
Actuate Therapeutics, Inc. Common stock Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.12 | $1.19 | +6.73% |
Jul 2026 | $1.50 | $1.11 | -25.67% |
Jun 2026 | $2.21 | $1.50 | -25.74% |
May 2026 | $3.10 | $2.02 | -30.58% |
Apr 2026 | $2.83 | $2.91 | +6.99% |
Mar 2026 | $3.60 | $2.72 | -28.42% |
Feb 2026 | $4.92 | $3.80 | -19.83% |
Jan 2026 | $6.01 | $4.74 | -22.30% |
Dec 2025 | $7.23 | $6.10 | -19.21% |
Nov 2025 | $6.52 | $7.55 | +13.19% |
Oct 2025 | $6.76 | $6.67 | -2.34% |
Sep 2025 | $8.75 | $6.83 | -18.84% |
ACTU Share Price FAQs
What is Actuate Therapeutics, Inc. Common stock share price today?
What is the 52 week high and 52 week low of Actuate Therapeutics, Inc. Common stock stock?
What is ACTU's market capitalisation today?
What is ACTU's net income for the last quarter?
What is the 5 year returns of ACTU?
What is the high & low stock price of ACTU today?
Can I buy ACTU shares in India?